Clinical Trial: Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Clinical Study of Central Venous-to-Arterial Carbon Dioxide Difference(Pcv-aCO2) in the Evaluation of Fluid Therapy for Postoperative Patients With Abdominal Cancer
Brief Summary: This research will confirm that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic effect of these patients.
Detailed Summary:
- Confirmed that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic efficacy of this kind of patients.
- Pcv-aCO2 effectively reflected the improvement of tissue and organ microcirculation disorder through the individual goal target treatment to guide the fluid resuscitation in the hemodynamic instability patients.
- Research of the correlation between Pcv-aCO2 and the organ function in patients with abnormal hemodynamics after operation.
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Current Primary Outcome: The change of Pcv-aCO2 [ Time Frame: fluid resuscitation for 6 hours, 12 hours and 24 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- The treatment success rate in different groups [ Time Frame: Twenty-eighth days after admission ]Collect the index of treatment success rate(%) of patients in different groups.
- The 28 day mortality in different groups [ Time Frame: Twenty-eighth days after admission ]Collect the index of 28 day mortality(%) of patients in different groups.
- The hospitalization course in different groups [ Time Frame: Twenty-eighth days after admission ]Collect the index of hospitalization course(days) of patients in different groups.
Original Secondary Outcome: Same as current
Information By: Tianjin Medical University Cancer Institute and Hospital
Dates:
Date Received: October 9, 2016
Date Started: October 2016
Date Completion: September 2018
Last Updated: November 27, 2016
Last Verified: October 2016